Automated causal inference in application to randomized controlled clinical trials

• URL: http://arxiv.org/abs/2201.05773v2
• Date: Wed, 19 Jan 2022 08:41:53 GMT
• Title: Automated causal inference in application to randomized controlled clinical trials
• Authors: Jiqing Wu, Nanda Horeweg, Marco de Bruyn, Remi A. Nout, Ina M. J\"urgenliemk-Schulz, Ludy C.H.W. Lutgens, Jan J. Jobsen, Elzbieta M. van der Steen-Banasik, Hans W. Nijman, Vincent T.H.B.M. Smit, Tjalling Bosse, Carien L. Creutzberg, Viktor H. Koelzer
• Abstract summary: We propose a new automated causal inference method (AutoCI) for causal re-interpretation of clinical trial data. We show that the proposed AutoCI allows to efficiently determine the causal variables with a clear differentiation on two real-world RCTs of endometrial cancer patients. In ablation studies, we demonstrate that the assignment of causal probabilities by AutoCI remain consistent in the presence of confounders.
• Score: 2.014647406790584
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: Randomized controlled trials (RCTs) are considered as the gold standard for testing causal hypotheses in the clinical domain. However, the investigation of prognostic variables of patient outcome in a hypothesized cause-effect route is not feasible using standard statistical methods. Here, we propose a new automated causal inference method (AutoCI) built upon the invariant causal prediction (ICP) framework for the causal re-interpretation of clinical trial data. Compared to existing methods, we show that the proposed AutoCI allows to efficiently determine the causal variables with a clear differentiation on two real-world RCTs of endometrial cancer patients with mature outcome and extensive clinicopathological and molecular data. This is achieved via suppressing the causal probability of non-causal variables by a wide margin. In ablation studies, we further demonstrate that the assignment of causal probabilities by AutoCI remain consistent in the presence of confounders. In conclusion, these results confirm the robustness and feasibility of AutoCI for future applications in real-world clinical analysis.

Related papers

• Testing Causal Explanations: A Case Study for Understanding the Effect of Interventions on Chronic Kidney Disease [1.2449538970962482]
  We developed a methodology that uses a large observational electronic health record dataset. Principles of regression discontinuity were used to derive randomized data subsets to test expert-driven interventions. This methodology demonstrates how real-world EHR data can be used to provide population-level insights to inform improved healthcare delivery.
  arXiv  Detail & Related papers  (2024-10-15T20:34:36Z)
• Ethical considerations of use of hold-out sets in clinical prediction model management [0.4194295877935868]
  We focus on the ethical principles of beneficence, non-maleficence, autonomy and justice. We also discuss statistical issues arising from different hold-out set sampling methods.
  arXiv  Detail & Related papers  (2024-06-05T11:42:46Z)
• Uncertainty Quantification on Clinical Trial Outcome Prediction [37.238845949535616]
  We propose incorporating uncertainty quantification into clinical trial outcome predictions. Our main goal is to enhance the model's ability to discern nuanced differences. We have adopted a selective classification approach to fulfill our objective.
  arXiv  Detail & Related papers  (2024-01-07T13:48:05Z)
• Simulation-based Inference for Cardiovascular Models [57.92535897767929]
  We use simulation-based inference to solve the inverse problem of mapping waveforms back to plausible physiological parameters. We perform an in-silico uncertainty analysis of five biomarkers of clinical interest. We study the gap between in-vivo and in-silico with the MIMIC-III waveform database.
  arXiv  Detail & Related papers  (2023-07-26T02:34:57Z)
• Continuous-Time Modeling of Counterfactual Outcomes Using Neural Controlled Differential Equations [84.42837346400151]
  Estimating counterfactual outcomes over time has the potential to unlock personalized healthcare. Existing causal inference approaches consider regular, discrete-time intervals between observations and treatment decisions. We propose a controllable simulation environment based on a model of tumor growth for a range of scenarios.
  arXiv  Detail & Related papers  (2022-06-16T17:15:15Z)
• Pragmatic Clinical Trials in the Rubric of Structural Causal Models [1.1049608786515839]
  Pragmatic clinical trials (PCT) fall between explanatory studies and observational studies. No standardized representation of PCT through structural causal models (SCM) has been yet established. We propose a generalized representation of PCT under the rubric of structural causal models (SCM)
  arXiv  Detail & Related papers  (2022-04-28T21:12:38Z)
• Causal Bias Quantification for Continuous Treatment [5.6968018940343885]
  We develop a novel characterization of marginal causal effect and causal bias in continuous treatment setting. We show they can be expressed as an expectation with respect to a conditional probability distribution. All terms in the expectations can be computed via automatic differentiation, also for highly non-linear models.
  arXiv  Detail & Related papers  (2021-06-17T18:44:48Z)
• Bayesian prognostic covariate adjustment [59.75318183140857]
  Historical data about disease outcomes can be integrated into the analysis of clinical trials in many ways. We build on existing literature that uses prognostic scores from a predictive model to increase the efficiency of treatment effect estimates.
  arXiv  Detail & Related papers  (2020-12-24T05:19:03Z)
• Increasing the efficiency of randomized trial estimates via linear adjustment for a prognostic score [59.75318183140857]
  Estimating causal effects from randomized experiments is central to clinical research. Most methods for historical borrowing achieve reductions in variance by sacrificing strict type-I error rate control.
  arXiv  Detail & Related papers  (2020-12-17T21:10:10Z)
• Personalized pathology test for Cardio-vascular disease: Approximate Bayesian computation with discriminative summary statistics learning [48.7576911714538]
  We propose a platelet deposition model and an inferential scheme to estimate the biologically meaningful parameters using approximate computation. This work opens up an unprecedented opportunity of personalized pathology test for CVD detection and medical treatment.
  arXiv  Detail & Related papers  (2020-10-13T15:20:21Z)
• Hemogram Data as a Tool for Decision-making in COVID-19 Management: Applications to Resource Scarcity Scenarios [62.997667081978825]
  COVID-19 pandemics has challenged emergency response systems worldwide, with widespread reports of essential services breakdown and collapse of health care structure. This work describes a machine learning model derived from hemogram exam data performed in symptomatic patients. Proposed models can predict COVID-19 qRT-PCR results in symptomatic individuals with high accuracy, sensitivity and specificity.
  arXiv  Detail & Related papers  (2020-05-10T01:45:03Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.